Sporadic Burkitt lymphoma in southern China: 12 Years' experience in a single institution in Guangzhou

Journal of Clinical Pathology

Volumn 64, Issue 12, 2011, Pages 1132-1135

  Ye, Ziyin ^a   Xiao, Yanhua ^a,b   Shi, Huijuan ^a   Ke, Zunfu ^a   Liu, Yongdong ^a   Liang, Yingjie ^a   Han, Anjia ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Provincial Lung Cancer Research Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 4;

ADOLESCENT; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CHILD; CHINA; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; MALE; NASOPHARYNX CANCER; NASOPHARYNX CARCINOMA; NK T CELL LYMPHOMA; PLEOMORPHIC ADENOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR CELL; VIRUS EXPRESSION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CHINA; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERFERON REGULATORY FACTORS; MALE; MIDDLE AGED; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; YOUNG ADULT;

EID: 81855213114     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200118     Document Type: Article

References (12)

1. Bornkamm GW. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Int J Cancer 2009;124:1745-55.
2. God JM, Haque A. Burkitt lymphoma: pathogenesis and immune evasion. J Oncol 2010;2010:516047.
3. Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol 2007;60:1397-402. (Pubitemid 350247257)
4. Swerdlow S, Campo E, Harris N, et al. WHO Classification of Tumours, Pathology & Genetics Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2008.
5. Yang J, Zhang F, Fang H, et al. Clinicopathologic features of primary lymphoma in soft tissue. Leuk Lymphoma 2010;51:2039-46.
6. Boerma EG, van Imhoff GW, Appel IM, et al. Gender and age-related differences in Burkitt lymphoma-epidemiological and clinical data from The Netherlands. Eur J Cancer 2004;40:2781-7. (Pubitemid 39574732)
7. Drillenburg P, Pals ST. Cell adhesion receptors in lymphoma dissemination. Blood 2000;95:1900-10. (Pubitemid 30151624)
8. Gualco G, Queiroga EM, Weiss LM, et al. Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma. Hum Pathol 2009;40:565-71.
9. Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006;354:2431-42. (Pubitemid 43855046)
10. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001;97:744-51. (Pubitemid 32113409)
11. Chuang SS, Ye H, Du MQ, et al. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH. Am J Clin Pathol 2007;128:558-64. (Pubitemid 47584432)
12. Bellan C, Lazzi S, Hummel M, et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005;106:1031-6. (Pubitemid 41076450)